The United States Food and Drug Administration (FDA) has issued an update on its inspection and assessment activities during the novel coronavirus (COVID-19) pandemic and its roadmap for future FDA operations.  FDA notes that its inspection, surveillance, and compliance activities were significantly impacted by the COVID-19 pandemic.  To read the FDA update on its regulatory operations during the COVID-19 pandemic and to access the FDA roadmap for future operations, use the link below.
https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-outlines-inspection-and-assessment-activities-during-pandemic?utm_medium=email&utm_source=govdelivery